
Dalila C Pinto, PhD
About Me
Dr. Pinto is a tenured Associate Professor of Psychiatry, Genetics and Genomic Sciences, and a faculty member of the Mindich Child Health and Development Institute, the Seaver Autism Center, the Friedman Brain Institute, and the Icahn Genomics Institute. Dr. Pinto’s laboratory focuses on identifying genes and biological pathways involved in various neurodevelopmental disorders, including autism, intellectual disability, epilepsy, and rett syndrome-like phenotypes. Dr. Pinto integrates various forms of genetic variation (deletions, duplications, indels, single-point mutations), with gene expression, epigenetics and clinical data, using a combination of innovative high-throughput experimental and bioinformatics approaches, that altogether could implicate novel risk factors and provide insights into the mechanisms underlying these disorders. Dr. Pinto’s laboratory also works with worldwide clinical collaborators that are responsible for patients and families recruitment and phenotypic examination.
Language
English
Position
ASSOCIATE PROFESSOR | Psychiatry, ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
Research Topics
Autism, Bioinformatics, Computational Biology, Epilepsy, Gene Expressions, Gene Regulation, Genetics, Genomics, Human Genetics and Genetic Disorders, RNA
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS], Neuroscience [NEU]
Education
MSc, MSc, University of Porto
PhD, University of Utrecht
Postdoctoral, Hospital for Sick Children Toronto
Research
Publications
Selected Publications
- Leveraging transdiagnostic genetic liability to psychiatric disorders to dissect clinical outcomes of anorexia nervosa. Zheng An Lu, Alexander Ploner, Andreas Birgegård, Sarah L. Maguire, Stephan Zipfel, Eleftheria Zeggini, D. Blake Woodside, H. Erich Wichmann, Thomas Werge, Hunna J. Watson, Tracey D. Wade, Annemarie van Elburg, Konstantinos Tziouvas, Artemis Tsitsika, Federica Tozzi, Alfonso Tortorella, Friederike I. Tam, Beata Świątkowska, Garret D. Stuber, Michael Strober, Vidar W. Steen, Nicole Soranzo, Agnieszka Slopien, Marta Tyszkiewicz-Nwafor, Eric F. van Furth, Margarita C.T. Slof-Op’t, Lenka Slachtova, Alexandra Schosser, Nicholas J. Schork, Janet Treasure, Ulrike Schmidt, Stephen W. Scherer, André Scherag, Paolo Santonastaso, Filip Rybakowski, Alessandro Rotondo, Stephan Ripke, Samuli Ripatti, Valdo Ricca, Ted Reichborn-Kjennerud, Anu Raevuori, John F. Pearson, Jacques Pantel, Aarno Palotie, Julie O’Toole, Nadia Micali, Dalila Pinto, Laura M. Huckins, Jessica S. Johnson, Jiayi Xu. Molecular Psychiatry
- Mapping the genetic landscape across 14 psychiatric disorders. Andrew D. Grotzinger, Josefin Werme, Wouter J. Peyrot, Oleksandr Frei, Christiaan de Leeuw, Lucy K. Bicks, Qiuyu Guo, Michael P. Margolis, Brandon J. Coombes, Anthony Batzler, Vanessa Pazdernik, Joanna M. Biernacka, Ole A. Andreassen, Verneri Anttila, Anders D. Børglum, Gerome Breen, Na Cai, Ditte Demontis, Howard J. Edenberg, Stephen V. Faraone, Barbara Franke, Michael J. Gandal, Joel Gelernter, Alexander S. Hatoum, John M. Hettema, Emma C. Johnson, Katherine G. Jonas, James A. Knowles, Karestan C. Koenen, Adam X. Maihofer, Travis T. Mallard, Manuel Mattheisen, Karen S. Mitchell, Benjamin M. Neale, Caroline M. Nievergelt, John I. Nurnberger, Kevin S. O’Connell, Roseann E. Peterson, Elise B. Robinson, Sandra S. Sanchez-Roige, Susan L. Santangelo, Jeremiah M. Scharf, Hreinn Stefansson, Kari Stefansson, Dan J. Stein, Niamh Mullins, Dalila Pinto, Nikolaos P. Daskalakis, David Cohen, Alison M. Goate. Nature
- Defining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group. Sarah M.C. Colbert, Eric T. Monson, Ole A. Andreassen, Olatunde O. Ayinde, Peter B. Barr, Cosmin A. Bejan, Zuriel Ceja, Hilary Coon, Emily DiBlasi, Howard J. Edenberg, Joel Gelernter, Alexander Hatoum, Anastasia Izotova, Emma C. Johnson, Erin A. Kaufman, Henry R. Kranzler, Maria Koromina, Kelli Lehto, Woojae Myung, John I. Nurnberger, Alessandro Serretti, Jordan W. Smoller, Murray B. Stein, Clement C. Zai, Annette Erlangsen, Marie Gaine, Lourdes Martorell, Reeteka Sud, Claudio Toma, Tim B. Bigdeli, Nathan A. Kimbrel, Douglas Ruderfer, Anna R. Docherty, J. John Mann, Niamh Mullins, Lea Zillich, Zeynep Yilmaz, Naomi R. Wray, D. Blake Woodside, Stephanie H. Witt, Virginia Willour, Leanne M. Williams, David C. Whiteman, Thomas Werge, Frank Wendt, Myrna M. Weissman, Thomas W. Weickert, Dalila Pinto, René S. Kahn, Douglas M. Ruderfer. Molecular Psychiatry
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Pinto has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.